| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | ZnF_C2HC | 3.75e-07 | 55 | 157 | 7 | SM00343 | |
| Domain | Znf_CCHC | 3.75e-07 | 55 | 157 | 7 | IPR001878 | |
| Domain | Cadherin_2 | 1.76e-05 | 65 | 157 | 6 | PF08266 | |
| Domain | Cadherin_N | 1.76e-05 | 65 | 157 | 6 | IPR013164 | |
| Domain | Cadherin_C | 2.61e-05 | 42 | 157 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 2.61e-05 | 42 | 157 | 5 | PF16492 | |
| Domain | Cadherin_CS | 3.77e-05 | 109 | 157 | 7 | IPR020894 | |
| Domain | CADHERIN_1 | 4.75e-05 | 113 | 157 | 7 | PS00232 | |
| Domain | Cadherin | 4.75e-05 | 113 | 157 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 5.03e-05 | 114 | 157 | 7 | PS50268 | |
| Domain | - | 5.03e-05 | 114 | 157 | 7 | 2.60.40.60 | |
| Domain | CA | 5.32e-05 | 115 | 157 | 7 | SM00112 | |
| Domain | Cadherin-like | 5.62e-05 | 116 | 157 | 7 | IPR015919 | |
| Domain | Cadherin | 6.27e-05 | 118 | 157 | 7 | IPR002126 | |
| Domain | Leu-rich_rpt | 1.01e-04 | 271 | 157 | 10 | IPR001611 | |
| Domain | - | 3.95e-04 | 321 | 157 | 10 | 3.80.10.10 | |
| Domain | L_dom-like | 4.67e-04 | 328 | 157 | 10 | IPR032675 | |
| Domain | LRR_1 | 5.39e-04 | 219 | 157 | 8 | PF00560 | |
| Domain | ARM-type_fold | CEP104 MYBBP1A NBEAL1 TOGARAM1 HUWE1 RALGAPA2 NOP9 PELP1 PI4KA ASPM | 6.04e-04 | 339 | 157 | 10 | IPR016024 |
| Domain | LRR_TYP | 7.54e-04 | 177 | 157 | 7 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 7.54e-04 | 177 | 157 | 7 | IPR003591 | |
| Domain | - | 1.03e-03 | 6 | 157 | 2 | 3.90.1290.10 | |
| Domain | Gphrmn_rcpt_fam | 1.03e-03 | 6 | 157 | 2 | IPR002131 | |
| Domain | CAMSAP_CH | 1.43e-03 | 7 | 157 | 2 | PF11971 | |
| Domain | Plectin | 1.43e-03 | 7 | 157 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.43e-03 | 7 | 157 | 2 | IPR001101 | |
| Domain | CAMSAP_CH | 1.43e-03 | 7 | 157 | 2 | IPR022613 | |
| Domain | PLEC | 1.43e-03 | 7 | 157 | 2 | SM00250 | |
| Pubmed | FAM90A14 FAM90A2P FAM90A1 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 4.15e-24 | 25 | 175 | 13 | 17684299 | |
| Pubmed | FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 4.88e-20 | 23 | 175 | 11 | 18602769 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A1 FAM90A17 FAM90A19 FAM90A22 FAM90A26 FAM90A23 PXYLP1 FAM90A7 FAM90A9 FAM90A8 FAM90A10 | 4.86e-11 | 164 | 175 | 12 | 22967998 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIF13B KIF26B HJURP C19orf47 USP43 IRS1 CEP192 AKT1S1 PABIR2 FAM171A1 ZNF106 WWC2 VPS13D PHLDB1 PANK2 PI4KA PHACTR4 RASSF8 PARD3 SRRM2 | 1.58e-08 | 861 | 175 | 20 | 36931259 |
| Pubmed | 4.44e-08 | 20 | 175 | 5 | 11322959 | ||
| Pubmed | 4.27e-07 | 13 | 175 | 4 | 12231349 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 1.77e-06 | 72 | 175 | 6 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 2.08e-06 | 74 | 175 | 6 | 10817752 | |
| Pubmed | 2.63e-06 | 77 | 175 | 6 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 3.29e-06 | 80 | 175 | 6 | 10716726 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.03e-05 | 57 | 175 | 5 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 1.12e-05 | 58 | 175 | 5 | 30377227 | |
| Pubmed | 1.21e-05 | 210 | 175 | 8 | 16565220 | ||
| Pubmed | 1.46e-05 | 10 | 175 | 3 | 22969705 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 2.46e-05 | 68 | 175 | 5 | 11230163 | |
| Pubmed | Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma. | 2.52e-05 | 2 | 175 | 2 | 21063024 | |
| Pubmed | HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease. | 2.52e-05 | 2 | 175 | 2 | 29415205 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 23460019 | ||
| Pubmed | Lack of effect from genetic deletion of Hdac6 in a humanized mouse model of CMT2D. | 2.52e-05 | 2 | 175 | 2 | 38551018 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 28887310 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 29520015 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 27785750 | ||
| Pubmed | Genetic contribution of the CD14 -159C/T dimorphism in the promoter region in Japanese RA. | 2.52e-05 | 2 | 175 | 2 | 18565258 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 35842608 | ||
| Pubmed | The human desmin locus: gene organization and LCR-mediated transcriptional control. | 2.52e-05 | 2 | 175 | 2 | 16545539 | |
| Pubmed | 2.64e-05 | 234 | 175 | 8 | 36243803 | ||
| Pubmed | 3.76e-05 | 246 | 175 | 8 | 15345747 | ||
| Pubmed | TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77. | 5.45e-05 | 15 | 175 | 3 | 19321449 | |
| Pubmed | 6.68e-05 | 16 | 175 | 3 | 29764992 | ||
| Pubmed | PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. | 7.53e-05 | 3 | 175 | 2 | 20440071 | |
| Pubmed | Association of TAP2 gene polymorphisms in Chinese patients with rheumatoid arthritis. | 7.53e-05 | 3 | 175 | 2 | 14749980 | |
| Pubmed | 7.53e-05 | 3 | 175 | 2 | 21350045 | ||
| Pubmed | 7.53e-05 | 3 | 175 | 2 | 31582733 | ||
| Pubmed | Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease. | 7.53e-05 | 3 | 175 | 2 | 17653770 | |
| Pubmed | 7.53e-05 | 3 | 175 | 2 | 17713555 | ||
| Pubmed | 7.53e-05 | 3 | 175 | 2 | 12729048 | ||
| Pubmed | 7.53e-05 | 3 | 175 | 2 | 19387463 | ||
| Pubmed | HLA haplotype analysis in Finnish patients with rheumatoid arthritis. | 7.53e-05 | 3 | 175 | 2 | 11229461 | |
| Pubmed | TAP1 and TAP2 gene polymorphism in rheumatoid arthritis in a population in eastern France. | 7.53e-05 | 3 | 175 | 2 | 12047361 | |
| Pubmed | 7.53e-05 | 3 | 175 | 2 | 23152903 | ||
| Pubmed | 9.64e-05 | 209 | 175 | 7 | 36779422 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAT4 KIF26B GARS1 PCDHB14 PIDD1 EVPL IRS1 ICE1 BCL3 HUWE1 MOGS PI4KA PKD1 | 9.81e-05 | 736 | 175 | 13 | 29676528 |
| Pubmed | EPPK1 GPAA1 GARS1 LGR4 QTRT2 NIPSNAP3A ELAC2 TMEM33 ZNF106 MISP ARHGEF40 MOGS PELP1 UBR5 GLS CERCAM MRPL40 SRRM2 | 1.03e-04 | 1297 | 175 | 18 | 33545068 | |
| Pubmed | 1.50e-04 | 4 | 175 | 2 | 16923132 | ||
| Pubmed | 1.50e-04 | 4 | 175 | 2 | 23589304 | ||
| Pubmed | 1.50e-04 | 4 | 175 | 2 | 20301515 | ||
| Pubmed | 1.50e-04 | 4 | 175 | 2 | 15343265 | ||
| Pubmed | 1.50e-04 | 4 | 175 | 2 | 26401052 | ||
| Pubmed | 1.50e-04 | 4 | 175 | 2 | 23055499 | ||
| Pubmed | 1.50e-04 | 4 | 175 | 2 | 25406310 | ||
| Pubmed | 1.50e-04 | 4 | 175 | 2 | 12786999 | ||
| Pubmed | 1.50e-04 | 4 | 175 | 2 | 19893491 | ||
| Pubmed | 1.56e-04 | 100 | 175 | 5 | 10048485 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 SPEG C19orf47 AKNA IRS1 ICE1 CEP192 HUWE1 RALGAPA2 ELAC2 PHLDB1 HEG1 ARHGEF40 COQ4 PI4KA PKD1 | 1.58e-04 | 1105 | 175 | 16 | 35748872 |
| Pubmed | DMXL2 TMEM201 MYBBP1A BCKDK MRPL27 SHMT1 CEP192 ELAC2 TMEM33 FAM171A1 MOGS UBR5 PI4KA GLS PHACTR4 ASPM MRPL40 PARD3 SRRM2 | 1.91e-04 | 1487 | 175 | 19 | 33957083 | |
| Pubmed | KIF13B DMXL2 PPFIA4 TOGARAM1 RALGAPA2 ELFN2 RFTN1 KRBA1 VPS13D GLS | 2.13e-04 | 493 | 175 | 10 | 15368895 | |
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | HTRA2 BCKDK GARS1 MRPL27 QTRT2 NIPSNAP3A HPDL ELAC2 VPS13D PANK2 PRELID3A FASTK COQ4 GLS MRPL40 TIMM29 | 2.15e-04 | 1136 | 175 | 16 | 34800366 |
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 2.27e-04 | 59 | 175 | 4 | 16083285 | |
| Pubmed | 2.49e-04 | 5 | 175 | 2 | 11581269 | ||
| Pubmed | Is TAP2*0102 allele involved in insulin-dependent diabetes mellitus (type 1) protection? | 2.49e-04 | 5 | 175 | 2 | 15336779 | |
| Pubmed | 2.49e-04 | 5 | 175 | 2 | 24870542 | ||
| Pubmed | 2.49e-04 | 5 | 175 | 2 | 28425671 | ||
| Pubmed | Dysfunction of the ciliary ARMC9/TOGARAM1 protein module causes Joubert syndrome. | 2.49e-04 | 5 | 175 | 2 | 32453716 | |
| Pubmed | HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex. | 2.49e-04 | 5 | 175 | 2 | 23612978 | |
| Pubmed | 2.49e-04 | 5 | 175 | 2 | 24334608 | ||
| Pubmed | Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation. | 3.73e-04 | 6 | 175 | 2 | 23362280 | |
| Pubmed | Doublecortin induces mitotic microtubule catastrophe and inhibits glioma cell invasion. | 3.73e-04 | 6 | 175 | 2 | 19094064 | |
| Pubmed | Interaction between 5 genetic variants and allergy in glioma risk. | 3.73e-04 | 6 | 175 | 2 | 20462933 | |
| Pubmed | Heart of glass anchors Rasip1 at endothelial cell-cell junctions to support vascular integrity. | 3.73e-04 | 6 | 175 | 2 | 26780829 | |
| Pubmed | Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. | 3.73e-04 | 6 | 175 | 2 | 21727895 | |
| Pubmed | Genetic risk profiles identify different molecular etiologies for glioma. | 3.73e-04 | 6 | 175 | 2 | 20847058 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | MYBBP1A HDAC6 GPAA1 SPEG BCKDK GARS1 NIPSNAP3A IRS1 SIRPB2 HPDL TMEM33 HEG1 MOGS GLS CERCAM TAP2 PARP12 SLC66A3 | 4.03e-04 | 1451 | 175 | 18 | 30550785 |
| Pubmed | 4.60e-04 | 30 | 175 | 3 | 19054571 | ||
| Pubmed | FAT4 EPPK1 CNTRL SEC22A MISP PHLDB1 LRFN4 UBR5 COQ4 PI4KA MEDAG TIMM29 | 4.66e-04 | 754 | 175 | 12 | 35906200 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TMEM201 MYBBP1A HDAC6 GARS1 HUWE1 ELAC2 TMEM33 PHLDB1 ARHGEF40 UBR5 PI4KA GLS ASPM DDX20 PARD3 SRRM2 PARP12 | 5.08e-04 | 1353 | 175 | 17 | 29467282 |
| Pubmed | 5.20e-04 | 7 | 175 | 2 | 28031293 | ||
| Pubmed | 5.20e-04 | 7 | 175 | 2 | 37651925 | ||
| Pubmed | Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice. | 5.20e-04 | 7 | 175 | 2 | 19118250 | |
| Pubmed | 5.20e-04 | 7 | 175 | 2 | 15548263 | ||
| Pubmed | 5.20e-04 | 7 | 175 | 2 | 18309376 | ||
| Pubmed | 5.20e-04 | 7 | 175 | 2 | 17242350 | ||
| Pubmed | Polycystin-1 binds Par3/aPKC and controls convergent extension during renal tubular morphogenesis. | 5.20e-04 | 7 | 175 | 2 | 24153433 | |
| Pubmed | Identification of novel cadherins expressed in human melanoma cells. | 5.20e-04 | 7 | 175 | 2 | 9182820 | |
| Pubmed | 5.20e-04 | 7 | 175 | 2 | 32457899 | ||
| Pubmed | Polymorphism of Immune Response Genes as a Factor for Predisposition to Development of Diseases. | 5.20e-04 | 7 | 175 | 2 | 12687213 | |
| Pubmed | A Role for Sensory end Organ-Derived Signals in Regulating Muscle Spindle Proprioceptor Phenotype. | 5.58e-04 | 32 | 175 | 3 | 30926747 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 6.86e-04 | 289 | 175 | 7 | 23752268 | |
| Pubmed | 6.91e-04 | 8 | 175 | 2 | 24616052 | ||
| Pubmed | Confirmation of the novel association at the BTNL2 locus with ulcerative colitis. | 6.91e-04 | 8 | 175 | 2 | 19659809 | |
| Pubmed | Genome-wide association study identifies five susceptibility loci for glioma. | 6.91e-04 | 8 | 175 | 2 | 19578367 | |
| Pubmed | 6.91e-04 | 8 | 175 | 2 | 24139799 | ||
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | HTRA2 BCKDK GARS1 MRPL27 SHMT1 NIPSNAP3A ELAC2 PANK2 PRELID3A FASTK COQ4 GLS MRPL40 | 8.72e-04 | 926 | 175 | 13 | 20877624 |
| Pubmed | GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. | 8.85e-04 | 9 | 175 | 2 | 15469820 | |
| Pubmed | 8.85e-04 | 9 | 175 | 2 | 11164852 | ||
| Pubmed | 8.85e-04 | 9 | 175 | 2 | 27340174 | ||
| Pubmed | The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling. | 8.85e-04 | 9 | 175 | 2 | 22033112 | |
| Pubmed | 8.85e-04 | 9 | 175 | 2 | 21531791 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | KIF13B MYBBP1A GPAA1 HTRA2 GARS1 QTRT2 AKT1S1 PABIR2 SOWAHA PANK2 DDX20 TIMM29 RASSF8 PARD3 PRAME RSPH10B | 1.09e-03 | 1321 | 175 | 16 | 27173435 |
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 1.10e-03 | 10 | 175 | 2 | 24618850 | |
| Pubmed | 1.14e-03 | 408 | 175 | 8 | 33766124 | ||
| Interaction | YWHAH interactions | KIF13B EPPK1 KIF26B SPEG CNTRL HJURP C19orf47 USP43 IRS1 CEP192 HUWE1 AKT1S1 PABIR2 FAM171A1 ZNF106 WWC2 VPS13D PHLDB1 PANK2 CDCA7 ARHGEF7 PI4KA PHACTR4 GPSM3 PPP1R9B RASSF8 PARD3 SRRM2 | 2.80e-08 | 1102 | 157 | 28 | int:YWHAH |
| Interaction | YWHAG interactions | KIF13B KIF26B SPEG HJURP C19orf47 USP43 LGR4 IRS1 CEP192 HUWE1 AKT1S1 PABIR2 FAM171A1 ZNF106 WWC2 VPS13D PHLDB1 LRFN4 PANK2 CDCA7 ARHGEF7 PI4KA PHACTR4 GPSM3 PPP1R9B RASSF8 PARD3 SRRM2 | 3.69e-07 | 1248 | 157 | 28 | int:YWHAG |
| Interaction | YWHAQ interactions | KIF13B EPPK1 HDAC6 KIF26B SPEG HJURP C19orf47 USP43 IRS1 CEP192 TERT AKT1S1 PABIR2 FAM171A1 DES ZNF106 WWC2 VPS13D PHLDB1 PANK2 CDCA7 PHACTR4 GPSM3 RASSF8 PARD3 | 1.81e-06 | 1118 | 157 | 25 | int:YWHAQ |
| Interaction | YWHAZ interactions | KIF13B DMXL2 HDAC6 KIF26B SPEG HJURP USP43 LGR4 IRS1 CEP192 HUWE1 TERT AKT1S1 PABIR2 FAM171A1 WWC2 VPS13D PHLDB1 PANK2 APH1A CDCA7 ARHGEF7 PHACTR4 GPSM3 PPP1R9B RASSF8 PARD3 | 3.53e-06 | 1319 | 157 | 27 | int:YWHAZ |
| Interaction | YWHAB interactions | KIF13B KIF26B SPEG HJURP USP43 IRS1 CEP192 AKT1S1 PABIR2 FAM171A1 ZNF106 WWC2 VPS13D PHLDB1 LRFN4 PANK2 ARHGEF7 PHACTR4 GPSM3 PPP1R9B RASSF8 PARD3 SRRM2 | 3.90e-06 | 1014 | 157 | 23 | int:YWHAB |
| Cytoband | 8p23.1 | FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 9.62e-13 | 154 | 175 | 12 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.31e-10 | 234 | 175 | 12 | chr8p23 |
| Cytoband | 5q31 | 5.62e-06 | 115 | 175 | 6 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 2.09e-05 | 298 | 175 | 8 | chr5q31 | |
| GeneFamily | Clustered protocadherins | 2.38e-05 | 64 | 97 | 5 | 20 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 1.70e-04 | 4 | 97 | 2 | 1244 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.31e-04 | 181 | 97 | 6 | 694 | |
| GeneFamily | EF-hand domain containing|Plakins | 7.81e-04 | 8 | 97 | 2 | 939 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP | 4.53e-06 | 200 | 162 | 9 | M7192 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-07 | 189 | 164 | 8 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-07 | 193 | 164 | 8 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-07 | 193 | 164 | 8 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.00e-07 | 200 | 164 | 8 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.00e-07 | 200 | 164 | 8 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 8.00e-07 | 200 | 164 | 8 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.43e-07 | 141 | 164 | 7 | a32947b13e888850c979a54c137512e4b96d2f36 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.43e-07 | 141 | 164 | 7 | 2cb651d63466fdcce011d1dd8de409ef439d03e7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.59e-06 | 164 | 164 | 7 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-06 | 185 | 164 | 7 | fb84fcf7f51f53489bcb3962fa9cb483e48257ed | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.93e-06 | 186 | 164 | 7 | 9d250d5ae7cf9129be05b41d70cb6c3a046c5f1e | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|(1)_Control_(PBS) / Stress and Cell class | 7.30e-06 | 192 | 164 | 7 | e16e49b302019474232ef4cc0ff217d33afe34cf | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 7.55e-06 | 193 | 164 | 7 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-06 | 194 | 164 | 7 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-06 | 194 | 164 | 7 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | mLN-B_cell-B_cell_cycling|mLN / Region, Cell class and subclass | 8.63e-06 | 197 | 164 | 7 | 806dddcca85c82bd642008d930c8db16b613d88e | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.63e-06 | 197 | 164 | 7 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | mLN-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 8.63e-06 | 197 | 164 | 7 | 2071526fe46de8359ea118ff78581eb4454aa55a | |
| ToppCell | mLN-(2)_B_cell-(24)_B_cell_cycling|mLN / shred on region, Cell_type, and subtype | 8.63e-06 | 197 | 164 | 7 | 70fff2d6723f259e18e7a21d22dc46d71f0759ce | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D231|Adult / Lineage, Cell type, age group and donor | 8.92e-06 | 198 | 164 | 7 | 79a415e19cedde13a88f5043d71557363f102322 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.53e-06 | 200 | 164 | 7 | 88d713dfc792e7609bf7ecfb28f87cb748088570 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | 89a6da2bdedc6b1ad0675c8753bf2b763a99af6a | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.57e-05 | 157 | 164 | 6 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 158 | 164 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 158 | 164 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 162 | 164 | 6 | 36ddebe3bb172c992739353b7b049b2dde98b559 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 3.28e-05 | 164 | 164 | 6 | a07c6e13c07a90bc37db0915eb14931eb8309a1e | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-05 | 169 | 164 | 6 | 88aa2246ede582c2e11de63228d76f520889ecb3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-05 | 169 | 164 | 6 | a6a5b00912b653fad2ca7f096deaf35c9ef85e5b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-05 | 169 | 164 | 6 | 42a9b8c77d2a4d68b01e4db38f8a1af53c9c814f | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.88e-05 | 169 | 164 | 6 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-05 | 169 | 164 | 6 | f086b50791e1c93e253eb5e8d6c4bf617b1416c3 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.01e-05 | 170 | 164 | 6 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.28e-05 | 172 | 164 | 6 | ebeda7ef181cac0109be750a98e7589c615d2724 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.42e-05 | 173 | 164 | 6 | a55f310c533432e9e26e400026a5b47245152976 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.42e-05 | 173 | 164 | 6 | 9c7386bf0a899882c733f0b4921a96afde032a7d | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.56e-05 | 174 | 164 | 6 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.56e-05 | 174 | 164 | 6 | 9bb8159a62640756d18ecbade3bf32bcbb7dd590 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.56e-05 | 174 | 164 | 6 | e70cc623a3a6aceec813ed852fec0c4240561133 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.56e-05 | 174 | 164 | 6 | b6725086fe5a2b057c7c495ec63c970ac52c2580 | |
| ToppCell | COVID-mDC1-|COVID / Condition, Cell_class and T cell subcluster | 4.71e-05 | 175 | 164 | 6 | 83a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15 | |
| ToppCell | COVID-mDC1|COVID / Condition, Cell_class and T cell subcluster | 4.71e-05 | 175 | 164 | 6 | b9280444016e21c28131a61df65cc5c56d402412 | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 4.86e-05 | 176 | 164 | 6 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | IIH-CD8-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 5.51e-05 | 180 | 164 | 6 | d1a8b25115c80e5a5bd0b8244167a98250ab9778 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.68e-05 | 181 | 164 | 6 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 181 | 164 | 6 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 5.68e-05 | 181 | 164 | 6 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 181 | 164 | 6 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 5.86e-05 | 182 | 164 | 6 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-05 | 183 | 164 | 6 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-T_NK_proliferative|Bac-SEP / Disease, Lineage and Cell Type | 6.22e-05 | 184 | 164 | 6 | 848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-05 | 187 | 164 | 6 | d69f4eee0304a7db226275ab77fc9d5d2b6f3a07 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.80e-05 | 187 | 164 | 6 | 106f50ad85a92403037214f0e94702230284837f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 187 | 164 | 6 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 187 | 164 | 6 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 187 | 164 | 6 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.80e-05 | 187 | 164 | 6 | be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.01e-05 | 188 | 164 | 6 | bcfc426b60d8e5a23a2360bfb68b32868fec9fbf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.01e-05 | 188 | 164 | 6 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.01e-05 | 188 | 164 | 6 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 7.01e-05 | 188 | 164 | 6 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.01e-05 | 188 | 164 | 6 | 15146fd2c5592ea84d20b1fdd172b39cd60b5bed | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 7.43e-05 | 190 | 164 | 6 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.43e-05 | 190 | 164 | 6 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.43e-05 | 190 | 164 | 6 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.43e-05 | 190 | 164 | 6 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 7.87e-05 | 192 | 164 | 6 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.87e-05 | 192 | 164 | 6 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.87e-05 | 192 | 164 | 6 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.87e-05 | 192 | 164 | 6 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 193 | 164 | 6 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-05 | 193 | 164 | 6 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-05 | 193 | 164 | 6 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-05 | 193 | 164 | 6 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 8.10e-05 | 193 | 164 | 6 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 193 | 164 | 6 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 8.33e-05 | 194 | 164 | 6 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.33e-05 | 194 | 164 | 6 | 2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.33e-05 | 194 | 164 | 6 | b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 8.33e-05 | 194 | 164 | 6 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.33e-05 | 194 | 164 | 6 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.33e-05 | 194 | 164 | 6 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 8.57e-05 | 195 | 164 | 6 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-05 | 195 | 164 | 6 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | Endothelial|World / shred by cell class for bronchial biopsy | 8.57e-05 | 195 | 164 | 6 | f0e46e859f7a9bdead3203889f7e20fa21f76ff0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-05 | 196 | 164 | 6 | 65d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-05 | 196 | 164 | 6 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 8.82e-05 | 196 | 164 | 6 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | tumor_Lung-Endothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 9.06e-05 | 197 | 164 | 6 | 6870b311c54a73723768276a58456620f5217d43 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.06e-05 | 197 | 164 | 6 | 491e12a5fca06b86443c0173f5fa750ea3b8a715 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.06e-05 | 197 | 164 | 6 | 947042f888335c0829d4d5daeb623973eadb3348 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.32e-05 | 198 | 164 | 6 | ab70bf89690410221ec7aa3149bb50ac34433f99 | |
| Disease | Usher syndrome type 2A (is_implicated_in) | 2.47e-05 | 2 | 147 | 2 | DOID:0110838 (is_implicated_in) | |
| Disease | USHER SYNDROME, TYPE IIA | 2.47e-05 | 2 | 147 | 2 | 276901 | |
| Disease | USHER SYNDROME, TYPE IIA | 2.47e-05 | 2 | 147 | 2 | C1848634 | |
| Disease | Usher syndrome type 2A | 2.47e-05 | 2 | 147 | 2 | cv:C1848634 | |
| Disease | Usher syndrome type 2 | 7.37e-05 | 3 | 147 | 2 | C0339534 | |
| Disease | gallbladder carcinoma (is_implicated_in) | 2.44e-04 | 5 | 147 | 2 | DOID:4948 (is_implicated_in) | |
| Disease | Usher Syndrome, Type II | 2.44e-04 | 5 | 147 | 2 | C1568249 | |
| Disease | glaucoma (biomarker_via_orthology) | 3.62e-04 | 28 | 147 | 3 | DOID:1686 (biomarker_via_orthology) | |
| Disease | polycystic liver disease (implicated_via_orthology) | 5.09e-04 | 7 | 147 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | helping behavior measurement | 6.77e-04 | 8 | 147 | 2 | EFO_0008538 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 8.67e-04 | 9 | 147 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | isovalerate measurement | 8.67e-04 | 9 | 147 | 2 | EFO_0021051 | |
| Disease | Congenital disorder of glycosylation | 8.99e-04 | 38 | 147 | 3 | cv:C0282577 | |
| Disease | resting heart rate | 9.22e-04 | 149 | 147 | 5 | EFO_0004351 | |
| Disease | Alzheimer disease, peptic ulcer disease | 9.71e-04 | 39 | 147 | 3 | MONDO_0004247, MONDO_0004975 | |
| Disease | celiac disease (is_implicated_in) | 1.08e-03 | 10 | 147 | 2 | DOID:10608 (is_implicated_in) | |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 1.08e-03 | 10 | 147 | 2 | EFO_1000650, HP_0000131 | |
| Disease | glaucoma (is_implicated_in) | 1.08e-03 | 10 | 147 | 2 | DOID:1686 (is_implicated_in) | |
| Disease | pulmonary tuberculosis (is_implicated_in) | 1.21e-03 | 42 | 147 | 3 | DOID:2957 (is_implicated_in) | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 1.32e-03 | 11 | 147 | 2 | DOID:0080822 (is_implicated_in) | |
| Disease | small vessel stroke | 1.38e-03 | 96 | 147 | 4 | EFO_1001504 | |
| Disease | anti-Epstein Barr virus antibody measurement | 1.57e-03 | 12 | 147 | 2 | EFO_0009273 | |
| Disease | rheumatoid arthritis, smoking status measurement, ACPA-positive rheumatoid arthritis | 1.85e-03 | 13 | 147 | 2 | EFO_0000685, EFO_0006527, EFO_0009459 | |
| Disease | diabetic angiopathy (is_implicated_in) | 1.85e-03 | 13 | 147 | 2 | DOID:11713 (is_implicated_in) | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 1.85e-03 | 13 | 147 | 2 | C1846647 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 2.16e-03 | 14 | 147 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 2.16e-03 | 14 | 147 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | allergic disease (is_implicated_in) | 2.48e-03 | 15 | 147 | 2 | DOID:1205 (is_implicated_in) | |
| Disease | sarcoidosis (is_implicated_in) | 2.83e-03 | 16 | 147 | 2 | DOID:11335 (is_implicated_in) | |
| Disease | IGA glomerulonephritis | 3.06e-03 | 58 | 147 | 3 | EFO_0004194 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 3.58e-03 | 18 | 147 | 2 | EFO_1000649, HP_0000131 | |
| Disease | cortical thickness | NBEAL1 PCDHB11 LGR4 TNRC6B ELAC2 ZNF106 VPS13D PHLDB1 ARHGEF40 PI4KA GLS PKD1 PARD3 | 3.85e-03 | 1113 | 147 | 13 | EFO_0004840 |
| Disease | Congenital hernia of foramen of Morgagni | 3.99e-03 | 19 | 147 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 3.99e-03 | 19 | 147 | 2 | C0265700 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 3.99e-03 | 19 | 147 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | Liver carcinoma | 4.01e-03 | 507 | 147 | 8 | C2239176 | |
| Disease | Coronary Arteriosclerosis | 4.22e-03 | 65 | 147 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 4.22e-03 | 65 | 147 | 3 | C1956346 | |
| Disease | Alzheimer's disease (is_implicated_in) | 4.36e-03 | 132 | 147 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | glaucoma (is_marker_for) | 4.42e-03 | 20 | 147 | 2 | DOID:1686 (is_marker_for) | |
| Disease | myelodysplastic syndrome (is_marker_for) | 4.42e-03 | 20 | 147 | 2 | DOID:0050908 (is_marker_for) | |
| Disease | Microcephaly | 4.60e-03 | 67 | 147 | 3 | C0025958 | |
| Disease | Congenital diaphragmatic hernia | 4.86e-03 | 21 | 147 | 2 | C0235833 | |
| Disease | Lymphoma, Diffuse | 4.86e-03 | 21 | 147 | 2 | C3714542 | |
| Disease | Low Grade Lymphoma (neoplasm) | 4.86e-03 | 21 | 147 | 2 | C0079747 | |
| Disease | Lymphoma, Intermediate-Grade | 4.86e-03 | 21 | 147 | 2 | C0079741 | |
| Disease | High Grade Lymphoma (neoplasm) | 4.86e-03 | 21 | 147 | 2 | C0079740 | |
| Disease | Diffuse Mixed-Cell Lymphoma | 4.86e-03 | 21 | 147 | 2 | C0079757 | |
| Disease | Lymphoma, Undifferentiated | 4.86e-03 | 21 | 147 | 2 | C0024306 | |
| Disease | Reticulosarcoma | 4.86e-03 | 21 | 147 | 2 | C0024302 | |
| Disease | Lymphoma, Mixed-Cell | 4.86e-03 | 21 | 147 | 2 | C0024304 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RARTGTELVLLTAAP | 21 | Q96B36 | |
| RSRSLSPLIGSETLP | 31 | Q7Z7A1 | |
| STPTLASRGILGLSR | 1491 | Q8TER5 | |
| ATTAAAPTLRRLALS | 321 | Q8N9M1 | |
| APTLRRLALSSRSGL | 326 | Q8N9M1 | |
| DALTSISAGVLSRLP | 71 | Q6ZNB7 | |
| TTLRIGRATDTLPAS | 56 | Q9H981 | |
| RTGESILSLLRDPSK | 311 | Q92685 | |
| SILLSISSLGRTLRG | 96 | A0A1B0GTL2 | |
| SFRLDPVSGRLSTIS | 631 | Q6V0I7 | |
| PVSGRLSTISSLDRE | 636 | Q6V0I7 | |
| TLLLSPCTSRRLTGL | 1231 | Q96L96 | |
| PSLDSLGRRSSLSRL | 751 | Q14155 | |
| LGRRSSLSRLEPSDL | 756 | Q14155 | |
| IRRNLASPEGTLATL | 1851 | Q8TDJ6 | |
| LSSPRTRTGDVLLAE | 46 | Q9UHI6 | |
| LGPALALRARSTSAT | 21 | O14874 | |
| LRTRLGSLALGAVPT | 46 | Q8TBR5 | |
| RGSVLASLSPLRKAS | 176 | A6NDY2 | |
| LLGASRTLSLALDNP | 56 | Q8IZT6 | |
| GLQGLETRRLSLPSS | 476 | Q8NCD3 | |
| LDVLFSLLRTSPTRG | 1111 | Q6ZS30 | |
| SDVQLILRRTGPSLS | 71 | Q8NHQ8 | |
| SSRLRLTGPVTDDAL | 916 | Q5U651 | |
| SALTRALASRTLAPQ | 6 | Q9UFN0 | |
| LPGSSAVRLASLRDL | 51 | Q14699 | |
| RGSVLASLSPLRKAS | 176 | A6NKC0 | |
| RDLLLRSPAGVSATL | 11 | O94925 | |
| TALKSTGLRTSDPRL | 161 | O94925 | |
| SSLLDPSTGLALDRL | 1036 | Q9NPG4 | |
| SSGVAPRLSRSAELI | 356 | P0C881 | |
| SSGVAPRLSRSAELI | 356 | B2RC85 | |
| RGSVLASLSPLRKAS | 176 | A8MXZ1 | |
| LRVLLSAQTSPARLS | 36 | Q14296 | |
| QPGLRRALSSDSILS | 386 | Q8IVT2 | |
| GSPLLLFLRDQTSSR | 316 | Q86U38 | |
| SSLSLGLLPERSATL | 111 | Q5VUB5 | |
| LPSLGTSRLTRADLG | 236 | A5PL33 | |
| RHTALGPRSASLLSL | 46 | Q9Y4H4 | |
| GPRSASLLSLQTELL | 51 | Q9Y4H4 | |
| LTDLGSRLLSQLERP | 181 | Q9P2G4 | |
| LISRGDLSVTASTRP | 621 | Q86YW9 | |
| RLLSTVIRALDTPSD | 46 | Q9P0N8 | |
| GILRAPRAASTESLV | 131 | O43292 | |
| TSNRRVLLDTSIGPL | 186 | Q2M2H8 | |
| LPGSSRRRLLSSSLQ | 746 | Q6PRD1 | |
| LSTALRARGLPVASV | 201 | Q02846 | |
| SLVPERSFEGLSSLR | 151 | Q9HBX8 | |
| GSLRKLTLSSNPLRS | 746 | P59045 | |
| RGSVLASLSPLRKAS | 176 | Q86YD7 | |
| LRKRGSIPTSLTALS | 621 | O75335 | |
| LASLSEDGRSPISIR | 101 | Q96BI3 | |
| RARSPHDLSLASLLG | 156 | Q5T4W7 | |
| RSSGLASKLPLRAVS | 1791 | Q2KJY2 | |
| ASKLPLRAVSGRISE | 1796 | Q2KJY2 | |
| LGLRSISTPSPESLR | 456 | Q86X51 | |
| LLLLGGLRASATSTP | 41 | Q96KR4 | |
| LLLLTLALSGTRARG | 16 | Q96SQ9 | |
| RGSVLASLSPLRKTS | 176 | A8MWA6 | |
| RGSVLASLSPLRKAS | 176 | P0C7W9 | |
| LRERLGALKVSPSAS | 691 | Q9H5P4 | |
| PGLLQESSRLRSLLE | 1146 | Q92817 | |
| LSLARSLAVQRPASL | 36 | P42356 | |
| PSEAIRGLSALQSLR | 121 | Q9BXB1 | |
| VGLLLSRGASPTLRT | 351 | E5RJM6 | |
| TDGGPRTLRSLTVSL | 336 | Q9ULI3 | |
| RGSVLASLSPLRKAS | 176 | P0DV74 | |
| RLGALRLGSTSPRTL | 91 | Q8NF86 | |
| TNSRLARPTRLSLGD | 851 | P35568 | |
| AVSSGPRLRLLLLES | 26 | Q8IZL8 | |
| GITILVRRSSSPAEL | 811 | Q2PPJ7 | |
| RGSVLASLSPLRKAS | 176 | P0DV73 | |
| PLLSASSRLGRALAE | 1051 | Q7Z6Z7 | |
| SSTLGRTRSLPITIE | 456 | Q8IZ21 | |
| STSVGLRNADTLPRL | 96 | A6NFQ7 | |
| RGSVLASLSPLRKAS | 176 | P0DV76 | |
| RPSLTSISSGELRSL | 11 | Q5VYS4 | |
| PSATTLLSRGIVARL | 246 | P51956 | |
| RLSLVIRSPSLLQSG | 1301 | Q9BQG0 | |
| VSSPAGILSLTLLER | 121 | Q96IR7 | |
| SSRLGPLLDILADSR | 706 | Q13724 | |
| LTRPSEFILLGLSSR | 56 | Q8NH94 | |
| RRSSSAPLIHGLSDL | 21 | Q7Z309 | |
| TPSILLALGSLFSSR | 686 | Q9H0J9 | |
| RGSPALSSEALVRVL | 536 | Q9Y5F2 | |
| LLFLRGTRIPSSTTL | 26 | Q9BZ23 | |
| RGSVLASLSPLRKAS | 176 | A6NJQ4 | |
| RGSPALSSEALVRVL | 536 | Q9Y5E9 | |
| RGSPALSSEALVRVL | 536 | Q9Y5E2 | |
| PTTLEARLRLLSSVT | 226 | Q9H974 | |
| RPDTRLQLTTGSSLF | 131 | P20848 | |
| PVLLTRTGDSSARLR | 531 | O60308 | |
| PLEATGLALSSLRLR | 136 | P08571 | |
| ESAGAISSPALTLRR | 131 | P05000 | |
| RALLTSGTSDPRARV | 36 | O43464 | |
| TLRSAKRLRLDTGSP | 1841 | Q9Y2F5 | |
| SQLSGLPRRLRSTSL | 136 | A8MY62 | |
| PDSILDTLTSRRLIS | 26 | Q9BX69 | |
| SSGSAIPLLLRELNR | 61 | P49184 | |
| SVFPLGSEARSLSLR | 216 | Q6ZN03 | |
| LRPSLALLARLSSLG | 421 | Q8WW52 | |
| LGSLRASRLGTTRTP | 66 | P17661 | |
| SALNLLSLLRSSEGP | 161 | Q9NSP4 | |
| ERPRISTSTLDLGKL | 101 | Q9Y3A0 | |
| VLSSPLALSGDTRPR | 21 | P01911 | |
| VSGLRSLTTLLRALG | 126 | P01588 | |
| SVPREVLRLSLSSES | 1161 | Q7Z591 | |
| LLRVGSVVLSSAPAL | 101 | Q9NVV2 | |
| SVRGSILSLSLLRAP | 876 | Q9NTJ4 | |
| SSASALRPGLRTTIL | 116 | Q8N2G4 | |
| LGLPVAVSTLARDRS | 36 | Q8TEP8 | |
| DLITALISPTTRGLR | 301 | Q9NYP3 | |
| RGSVLASLSPLRKAS | 176 | A6NIJ5 | |
| RLSPSLRLSLASSAP | 1731 | A6NE01 | |
| PSTLIGSLRTLELGS | 1046 | Q9UBN7 | |
| SGSQKTLRSPRLDLT | 566 | Q5T4B2 | |
| LLPLVRTLVRSGADS | 321 | P20749 | |
| RGSVLASLSPLRKAS | 176 | A8MXJ8 | |
| LDLSGSRETPSSILL | 1121 | Q9ULU4 | |
| SASVIRVRDGLPLSA | 6 | Q96IW7 | |
| SHLGRRPTLAASLLL | 401 | Q96S37 | |
| RGSVLASLSPLRKAS | 176 | P0C7X0 | |
| SLPASLAGLRSLRLL | 231 | Q9HB75 | |
| RSGTFPLALVLSSRV | 1351 | P98161 | |
| RRLSAGLSLPLLTSV | 3891 | P98161 | |
| LVLLLSGRPTRADSK | 16 | Q68BL7 | |
| RGSPALSSEALVRVL | 536 | Q9Y5E6 | |
| RRSSDPALIGLSTSV | 141 | Q8TEW0 | |
| IISTILRIPSASGRS | 221 | Q8NGZ6 | |
| RGSPALSSEALVRVL | 536 | Q9Y5E1 | |
| LRLGTPALTSRGLLE | 401 | P34896 | |
| LRLGAPEARRSATLS | 1781 | Q9NQT8 | |
| ASISLTESRGLFPRL | 26 | O75445 | |
| LRSISLALRPTSGLL | 6 | Q9NQ50 | |
| IALALTAISLGTARP | 2181 | Q9UQ35 | |
| SGTLLLLAPATRNRE | 91 | Q9BSF4 | |
| TSPRRLVELAGQSLL | 21 | P78395 | |
| PTVLRARASGIDLTA | 461 | Q63ZE4 | |
| RGSVLASLSPLRKAS | 176 | A8MX19 | |
| RGSVLASLSPLRKAS | 176 | A6NNJ1 | |
| RGSVLASLSPLRKAS | 176 | P0C7W8 | |
| RGSALASLSPLRKAS | 176 | D6RGX4 | |
| GTLDLPALTRRLTAI | 3096 | P58107 | |
| SGTLDLPALTRRLTA | 3626 | P58107 | |
| GTLDLPALTRRLTAI | 4161 | P58107 | |
| SGTLDLPALTRRLTA | 4696 | P58107 | |
| ARPSLLLRRSLSAAS | 26 | P41250 | |
| LPSLVRAILGTSRTL | 61 | Q96N28 | |
| SDLGPIKSLRTLRAL | 1281 | Q15858 | |
| SLSVQGLSRASPVRL | 156 | Q9BRY0 | |
| LATPLTVSLRALVAG | 71 | Q03519 | |
| PVLAALRDLSRRGST | 61 | Q2M3A8 | |
| TLSPVLSALGLSEAR | 381 | Q8TE99 | |
| RGSVLASLSPLRKAS | 176 | P0C7V4 | |
| SSPLLRGSHSLELRA | 656 | Q8WZ75 | |
| TRSRSRILGSLDALP | 181 | Q9BWT1 | |
| ALLLALATSRRSPGQ | 306 | Q5JXA9 | |
| SELDRPLQGTLTLLR | 986 | Q70EL4 | |
| PATLSLSLSLTLSGR | 386 | P47901 | |
| LVASLGLSTSRPRVV | 36 | O75467 | |
| LSVRGTPSRALAERL | 386 | Q6AWC2 | |
| ISSPAVERLISSLLR | 616 | Q9BQ52 | |
| LGARRLQESPSLSAL | 2156 | Q15772 | |
| RESPLSLGLRLLSRS | 2341 | Q15772 | |
| RSLEGSSDTALPLRR | 441 | Q8WYR1 | |
| SSPLLLRRLSVEESG | 251 | Q2M3V2 | |
| IDLSLPSLGLGRSRE | 1156 | O75038 | |
| ATPRTSLLRLTELES | 586 | Q9NSD5 | |
| RGSVLASLSPLRKAS | 176 | Q658T7 | |
| LSRLSGVGLRLTTSL | 281 | Q9NS37 | |
| AERIPTLQTRGLSLS | 46 | P19237 | |
| ARLSRPDSGILASRI | 326 | Q9HBU9 | |
| LRDGGRLSATTVPLT | 281 | O75678 | |
| RALSLGTIPSLTRAD | 451 | Q5SNT2 | |
| GSGRLSTAITLLPLE | 46 | Q86UU1 | |
| SAVLAARSARGLSLP | 26 | Q8N755 | |
| ARSARGLSLPSLLLE | 31 | Q8N755 | |
| TDARLRASTALLLPI | 226 | Q9Y4F4 | |
| LALRTRTAVTSLLSP | 6 | Q9P0M9 | |
| DLPLVIGSRSGLSSR | 291 | Q9H3M7 | |
| VSISSSPGLARKRSL | 846 | Q9H2Y7 | |
| LLSSLRPSLTGARRL | 346 | O14746 | |
| LDARGSNSLPLLRSV | 131 | P57088 | |
| LARASLALPTSSLSR | 676 | Q9NQA5 | |
| TLLSRTDLDPRVLSN | 606 | Q9UPQ9 | |
| SSLSRLGSSRVLLLP | 286 | O95071 | |
| LGSSRVLLLPLERDS | 291 | O95071 | |
| PSLISIDLSSNRLSR | 151 | Q5R3F8 | |
| TVSLPELRSLLASGR | 6 | Q8NFU3 | |
| TLSRLSRTPIALATG | 111 | Q9UKW4 | |
| LAESLPRRNSSLLSV | 536 | Q5THJ4 | |
| RGSVLASLSPLRKAS | 176 | P0DV75 | |
| SRLDLTSNRLATLAP | 196 | Q6PJG9 | |
| ASERGVRLSLPRASS | 86 | Q96SB3 |